Global Molecular Diagnostics Cancer Market Size, Status and Forecast 2024-2031

Report ID: 934704 | Published Date: Jan 2025 | No. of Page: 125 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Molecular Diagnostics Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Pharmacogenomic Diagnosis
        1.2.3 Liquid Biopsy
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Molecular Diagnostics Cancer Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Respiratory Cancer
        1.3.3 Cancer of Digestive System
        1.3.4 Cancer of Urinary System
        1.3.5 Cancer of Circulatory System
        1.3.6 Motor System Cancer
        1.3.7 Reproductive System Cancer
        1.3.8 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Molecular Diagnostics Cancer Market Perspective (2016-2027)
    2.2 Molecular Diagnostics Cancer Growth Trends by Regions
        2.2.1 Molecular Diagnostics Cancer Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Molecular Diagnostics Cancer Historic Market Share by Regions (2016-2021)
        2.2.3 Molecular Diagnostics Cancer Forecasted Market Size by Regions (2022-2027)
    2.3 Molecular Diagnostics Cancer Industry Dynamic
        2.3.1 Molecular Diagnostics Cancer Market Trends
        2.3.2 Molecular Diagnostics Cancer Market Drivers
        2.3.3 Molecular Diagnostics Cancer Market Challenges
        2.3.4 Molecular Diagnostics Cancer Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Molecular Diagnostics Cancer Players by Revenue
        3.1.1 Global Top Molecular Diagnostics Cancer Players by Revenue (2016-2021)
        3.1.2 Global Molecular Diagnostics Cancer Revenue Market Share by Players (2016-2021)
    3.2 Global Molecular Diagnostics Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Molecular Diagnostics Cancer Revenue
    3.4 Global Molecular Diagnostics Cancer Market Concentration Ratio
        3.4.1 Global Molecular Diagnostics Cancer Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Cancer Revenue in 2020
    3.5 Molecular Diagnostics Cancer Key Players Head office and Area Served
    3.6 Key Players Molecular Diagnostics Cancer Product Solution and Service
    3.7 Date of Enter into Molecular Diagnostics Cancer Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Molecular Diagnostics Cancer Breakdown Data by Type
    4.1 Global Molecular Diagnostics Cancer Historic Market Size by Type (2016-2021)
    4.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2022-2027)

5 Molecular Diagnostics Cancer Breakdown Data by Application
    5.1 Global Molecular Diagnostics Cancer Historic Market Size by Application (2016-2021)
    5.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Molecular Diagnostics Cancer Market Size (2016-2027)
    6.2 North America Molecular Diagnostics Cancer Market Size by Type
        6.2.1 North America Molecular Diagnostics Cancer Market Size by Type (2016-2021)
        6.2.2 North America Molecular Diagnostics Cancer Market Size by Type (2022-2027)
        6.2.3 North America Molecular Diagnostics Cancer Market Size by Type (2016-2027)
    6.3 North America Molecular Diagnostics Cancer Market Size by Application
        6.3.1 North America Molecular Diagnostics Cancer Market Size by Application (2016-2021)
        6.3.2 North America Molecular Diagnostics Cancer Market Size by Application (2022-2027)
        6.3.3 North America Molecular Diagnostics Cancer Market Size by Application (2016-2027)
    6.4 North America Molecular Diagnostics Cancer Market Size by Country
        6.4.1 North America Molecular Diagnostics Cancer Market Size by Country (2016-2021)
        6.4.2 North America Molecular Diagnostics Cancer Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Molecular Diagnostics Cancer Market Size (2016-2027)
    7.2 Europe Molecular Diagnostics Cancer Market Size by Type
        7.2.1 Europe Molecular Diagnostics Cancer Market Size by Type (2016-2021)
        7.2.2 Europe Molecular Diagnostics Cancer Market Size by Type (2022-2027)
        7.2.3 Europe Molecular Diagnostics Cancer Market Size by Type (2016-2027)
    7.3 Europe Molecular Diagnostics Cancer Market Size by Application
        7.3.1 Europe Molecular Diagnostics Cancer Market Size by Application (2016-2021)
        7.3.2 Europe Molecular Diagnostics Cancer Market Size by Application (2022-2027)
        7.3.3 Europe Molecular Diagnostics Cancer Market Size by Application (2016-2027)
    7.4 Europe Molecular Diagnostics Cancer Market Size by Country
        7.4.1 Europe Molecular Diagnostics Cancer Market Size by Country (2016-2021)
        7.4.2 Europe Molecular Diagnostics Cancer Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Molecular Diagnostics Cancer Market Size (2016-2027)
    8.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Type
        8.2.1 Asia-Pacific Molecular Diagnostics Cancer Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Molecular Diagnostics Cancer Market Size by Type (2016-2027)
    8.3 Asia-Pacific Molecular Diagnostics Cancer Market Size by Application
        8.3.1 Asia-Pacific Molecular Diagnostics Cancer Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Molecular Diagnostics Cancer Market Size by Application (2016-2027)
    8.4 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region
        8.4.1 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Molecular Diagnostics Cancer Market Size (2016-2027)
    9.2 Latin America Molecular Diagnostics Cancer Market Size by Type
        9.2.1 Latin America Molecular Diagnostics Cancer Market Size by Type (2016-2021)
        9.2.2 Latin America Molecular Diagnostics Cancer Market Size by Type (2022-2027)
        9.2.3 Latin America Molecular Diagnostics Cancer Market Size by Type (2016-2027)
    9.3 Latin America Molecular Diagnostics Cancer Market Size by Application
        9.3.1 Latin America Molecular Diagnostics Cancer Market Size by Application (2016-2021)
        9.3.2 Latin America Molecular Diagnostics Cancer Market Size by Application (2022-2027)
        9.3.3 Latin America Molecular Diagnostics Cancer Market Size by Application (2016-2027)
    9.4 Latin America Molecular Diagnostics Cancer Market Size by Country
        9.4.1 Latin America Molecular Diagnostics Cancer Market Size by Country (2016-2021)
        9.4.2 Latin America Molecular Diagnostics Cancer Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Molecular Diagnostics Cancer Market Size (2016-2027)
    10.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type
        10.2.1 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2016-2027)
    10.3 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application
        10.3.1 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2016-2027)
    10.4 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country
        10.4.1 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Molecular Diagnostics Cancer Introduction
        11.1.4 Roche Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.1.5 Roche Recent Development
    11.2 Danaher
        11.2.1 Danaher Company Details
        11.2.2 Danaher Business Overview
        11.2.3 Danaher Molecular Diagnostics Cancer Introduction
        11.2.4 Danaher Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.2.5 Danaher Recent Development
    11.3 Siemens
        11.3.1 Siemens Company Details
        11.3.2 Siemens Business Overview
        11.3.3 Siemens Molecular Diagnostics Cancer Introduction
        11.3.4 Siemens Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.3.5 Siemens Recent Development
    11.4 Abbott Laboratories
        11.4.1 Abbott Laboratories Company Details
        11.4.2 Abbott Laboratories Business Overview
        11.4.3 Abbott Laboratories Molecular Diagnostics Cancer Introduction
        11.4.4 Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.4.5 Abbott Laboratories Recent Development
    11.5 ICON Plc
        11.5.1 ICON Plc Company Details
        11.5.2 ICON Plc Business Overview
        11.5.3 ICON Plc Molecular Diagnostics Cancer Introduction
        11.5.4 ICON Plc Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.5.5 ICON Plc Recent Development
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Details
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Molecular Diagnostics Cancer Introduction
        11.6.4 AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.6.5 AstraZeneca Recent Development
    11.7 MDxHealth
        11.7.1 MDxHealth Company Details
        11.7.2 MDxHealth Business Overview
        11.7.3 MDxHealth Molecular Diagnostics Cancer Introduction
        11.7.4 MDxHealth Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.7.5 MDxHealth Recent Development
    11.8 Invitae
        11.8.1 Invitae Company Details
        11.8.2 Invitae Business Overview
        11.8.3 Invitae Molecular Diagnostics Cancer Introduction
        11.8.4 Invitae Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.8.5 Invitae Recent Development
    11.9 PlexBio
        11.9.1 PlexBio Company Details
        11.9.2 PlexBio Business Overview
        11.9.3 PlexBio Molecular Diagnostics Cancer Introduction
        11.9.4 PlexBio Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.9.5 PlexBio Recent Development
    11.10 Thermo Fisher Scientific
        11.10.1 Thermo Fisher Scientific Company Details
        11.10.2 Thermo Fisher Scientific Business Overview
        11.10.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Introduction
        11.10.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.10.5 Thermo Fisher Scientific Recent Development
    11.11 Guardant Health
        11.11.1 Guardant Health Company Details
        11.11.2 Guardant Health Business Overview
        11.11.3 Guardant Health Molecular Diagnostics Cancer Introduction
        11.11.4 Guardant Health Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.11.5 Guardant Health Recent Development
    11.12 Biocartis
        11.12.1 Biocartis Company Details
        11.12.2 Biocartis Business Overview
        11.12.3 Biocartis Molecular Diagnostics Cancer Introduction
        11.12.4 Biocartis Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.12.5 Biocartis Recent Development
    11.13 Bio-Techne
        11.13.1 Bio-Techne Company Details
        11.13.2 Bio-Techne Business Overview
        11.13.3 Bio-Techne Molecular Diagnostics Cancer Introduction
        11.13.4 Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.13.5 Bio-Techne Recent Development
    11.14 Merck
        11.14.1 Merck Company Details
        11.14.2 Merck Business Overview
        11.14.3 Merck Molecular Diagnostics Cancer Introduction
        11.14.4 Merck Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.14.5 Merck Recent Development
    11.15 Foundation Medicine
        11.15.1 Foundation Medicine Company Details
        11.15.2 Foundation Medicine Business Overview
        11.15.3 Foundation Medicine Molecular Diagnostics Cancer Introduction
        11.15.4 Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.15.5 Foundation Medicine Recent Development
    11.16 10X Genomics
        11.16.1 10X Genomics Company Details
        11.16.2 10X Genomics Business Overview
        11.16.3 10X Genomics Molecular Diagnostics Cancer Introduction
        11.16.4 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.16.5 10X Genomics Recent Development
    11.17 Biodesix
        11.17.1 Biodesix Company Details
        11.17.2 Biodesix Business Overview
        11.17.3 Biodesix Molecular Diagnostics Cancer Introduction
        11.17.4 Biodesix Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.17.5 Biodesix Recent Development
    11.18 CytoTrack
        11.18.1 CytoTrack Company Details
        11.18.2 CytoTrack Business Overview
        11.18.3 CytoTrack Molecular Diagnostics Cancer Introduction
        11.18.4 CytoTrack Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.18.5 CytoTrack Recent Development
    11.18 GenomOncology
        .1 GenomOncology Company Details
        .2 GenomOncology Business Overview
        .3 GenomOncology Molecular Diagnostics Cancer Introduction
        .4 GenomOncology Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        .5 GenomOncology Recent Development
    11.20 Luminex
        11.20.1 Luminex Company Details
        11.20.2 Luminex Business Overview
        11.20.3 Luminex Molecular Diagnostics Cancer Introduction
        11.20.4 Luminex Revenue in Molecular Diagnostics Cancer Business (2016-2021)
        11.20.5 Luminex Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Molecular Diagnostics Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Pharmacogenomic Diagnosis
    Table 3. Key Players of Liquid Biopsy
    Table 4. Key Players of Other
    Table 5. Global Molecular Diagnostics Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Molecular Diagnostics Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Molecular Diagnostics Cancer Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Molecular Diagnostics Cancer Market Share by Regions (2016-2021)
    Table 9. Global Molecular Diagnostics Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Molecular Diagnostics Cancer Market Share by Regions (2022-2027)
    Table 11. Molecular Diagnostics Cancer Market Trends
    Table 12. Molecular Diagnostics Cancer Market Drivers
    Table 13. Molecular Diagnostics Cancer Market Challenges
    Table 14. Molecular Diagnostics Cancer Market Restraints
    Table 15. Global Molecular Diagnostics Cancer Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Molecular Diagnostics Cancer Market Share by Players (2016-2021)
    Table 17. Global Top Molecular Diagnostics Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics Cancer as of 2020)
    Table 18. Ranking of Global Top Molecular Diagnostics Cancer Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Molecular Diagnostics Cancer Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Molecular Diagnostics Cancer Product Solution and Service
    Table 22. Date of Enter into Molecular Diagnostics Cancer Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Molecular Diagnostics Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2016-2021)
    Table 26. Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Molecular Diagnostics Cancer Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Molecular Diagnostics Cancer Revenue Market Share by Application (2016-2021)
    Table 30. Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Molecular Diagnostics Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Molecular Diagnostics Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Molecular Diagnostics Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Molecular Diagnostics Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Molecular Diagnostics Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Molecular Diagnostics Cancer Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Molecular Diagnostics Cancer Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Molecular Diagnostics Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Molecular Diagnostics Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Molecular Diagnostics Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Molecular Diagnostics Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Molecular Diagnostics Cancer Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Molecular Diagnostics Cancer Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Molecular Diagnostics Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Molecular Diagnostics Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Molecular Diagnostics Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Molecular Diagnostics Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Molecular Diagnostics Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Molecular Diagnostics Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Molecular Diagnostics Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Molecular Diagnostics Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Molecular Diagnostics Cancer Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Molecular Diagnostics Cancer Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Roche Company Details
    Table 63. Roche Business Overview
    Table 64. Roche Molecular Diagnostics Cancer Product
    Table 65. Roche Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 66. Roche Recent Development
    Table 67. Danaher Company Details
    Table 68. Danaher Business Overview
    Table 69. Danaher Molecular Diagnostics Cancer Product
    Table 70. Danaher Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 71. Danaher Recent Development
    Table 72. Siemens Company Details
    Table 73. Siemens Business Overview
    Table 74. Siemens Molecular Diagnostics Cancer Product
    Table 75. Siemens Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 76. Siemens Recent Development
    Table 77. Abbott Laboratories Company Details
    Table 78. Abbott Laboratories Business Overview
    Table 79. Abbott Laboratories Molecular Diagnostics Cancer Product
    Table 80. Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 81. Abbott Laboratories Recent Development
    Table 82. ICON Plc Company Details
    Table 83. ICON Plc Business Overview
    Table 84. ICON Plc Molecular Diagnostics Cancer Product
    Table 85. ICON Plc Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 86. ICON Plc Recent Development
    Table 87. AstraZeneca Company Details
    Table 88. AstraZeneca Business Overview
    Table 89. AstraZeneca Molecular Diagnostics Cancer Product
    Table 90. AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 91. AstraZeneca Recent Development
    Table 92. MDxHealth Company Details
    Table 93. MDxHealth Business Overview
    Table 94. MDxHealth Molecular Diagnostics Cancer Product
    Table 95. MDxHealth Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 96. MDxHealth Recent Development
    Table 97. Invitae Company Details
    Table 98. Invitae Business Overview
    Table 99. Invitae Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 100. Invitae Recent Development
    Table 101. PlexBio Company Details
    Table 102. PlexBio Business Overview
    Table 103. PlexBio Molecular Diagnostics Cancer Product
    Table 104. PlexBio Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 105. PlexBio Recent Development
    Table 106. Thermo Fisher Scientific Company Details
    Table 107. Thermo Fisher Scientific Business Overview
    Table 108. Thermo Fisher Scientific Molecular Diagnostics Cancer Product
    Table 109. Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 110. Thermo Fisher Scientific Recent Development
    Table 111. Guardant Health Company Details
    Table 112. Guardant Health Business Overview
    Table 113. Guardant Health Molecular Diagnostics Cancer Product
    Table 114. Guardant Health Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 115. Guardant Health Recent Development
    Table 116. Biocartis Company Details
    Table 117. Biocartis Business Overview
    Table 118. Biocartis Molecular Diagnostics Cancer Product
    Table 119. Biocartis Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 120. Biocartis Recent Development
    Table 121. Bio-Techne Company Details
    Table 122. Bio-Techne Business Overview
    Table 123. Bio-Techne Molecular Diagnostics Cancer Product
    Table 124. Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 125. Bio-Techne Recent Development
    Table 126. Merck Company Details
    Table 127. Merck Business Overview
    Table 128. Merck Molecular Diagnostics Cancer Product
    Table 129. Merck Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 130. Merck Recent Development
    Table 131. Foundation Medicine Company Details
    Table 132. Foundation Medicine Business Overview
    Table 133. Foundation Medicine Molecular Diagnostics Cancer Product
    Table 134. Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 135. Foundation Medicine Recent Development
    Table 136. 10X Genomics Company Details
    Table 137. 10X Genomics Business Overview
    Table 138. 10X Genomics Molecular Diagnostics Cancer Product
    Table 139. 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 140. 10X Genomics Recent Development
    Table 141. Biodesix Company Details
    Table 142. Biodesix Business Overview
    Table 143. Biodesix Molecular Diagnostics Cancer Product
    Table 144. Biodesix Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 145. Biodesix Recent Development
    Table 146. CytoTrack Company Details
    Table 147. CytoTrack Business Overview
    Table 148. CytoTrack Molecular Diagnostics Cancer Product
    Table 149. CytoTrack Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 150. CytoTrack Recent Development
    Table 151. GenomOncology Company Details
    Table 152. GenomOncology Business Overview
    Table 153. GenomOncology Molecular Diagnostics Cancer Product
    Table 154. GenomOncology Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 155. GenomOncology Recent Development
    Table 156. Luminex Company Details
    Table 157. Luminex Business Overview
    Table 158. Luminex Molecular Diagnostics Cancer Product
    Table 159. Luminex Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
    Table 160. Luminex Recent Development
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Molecular Diagnostics Cancer Market Share by Type: 2020 VS 2027
    Figure 2. Pharmacogenomic Diagnosis Features
    Figure 3. Liquid Biopsy Features
    Figure 4. Other Features
    Figure 5. Global Molecular Diagnostics Cancer Market Share by Application: 2020 VS 2027
    Figure 6. Respiratory Cancer Case Studies
    Figure 7. Cancer of Digestive System Case Studies
    Figure 8. Cancer of Urinary System Case Studies
    Figure 9. Cancer of Circulatory System Case Studies
    Figure 10. Motor System Cancer Case Studies
    Figure 11. Reproductive System Cancer Case Studies
    Figure 12. Other Case Studies
    Figure 13. Molecular Diagnostics Cancer Report Years Considered
    Figure 14. Global Molecular Diagnostics Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 15. Global Molecular Diagnostics Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 16. Global Molecular Diagnostics Cancer Market Share by Regions: 2020 VS 2027
    Figure 17. Global Molecular Diagnostics Cancer Market Share by Regions (2022-2027)
    Figure 18. Global Molecular Diagnostics Cancer Market Share by Players in 2020
    Figure 19. Global Top Molecular Diagnostics Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics Cancer as of 2020
    Figure 20. The Top 10 and 5 Players Market Share by Molecular Diagnostics Cancer Revenue in 2020
    Figure 21. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2016-2021)
    Figure 22. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2022-2027)
    Figure 23. North America Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. North America Molecular Diagnostics Cancer Market Share by Type (2016-2027)
    Figure 25. North America Molecular Diagnostics Cancer Market Share by Application (2016-2027)
    Figure 26. North America Molecular Diagnostics Cancer Market Share by Country (2016-2027)
    Figure 27. United States Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Canada Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Molecular Diagnostics Cancer Market Share by Type (2016-2027)
    Figure 31. Europe Molecular Diagnostics Cancer Market Share by Application (2016-2027)
    Figure 32. Europe Molecular Diagnostics Cancer Market Share by Country (2016-2027)
    Figure 33. Germany Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. France Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. U.K. Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Italy Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Russia Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Nordic Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Molecular Diagnostics Cancer Market Share by Type (2016-2027)
    Figure 41. Asia-Pacific Molecular Diagnostics Cancer Market Share by Application (2016-2027)
    Figure 42. Asia-Pacific Molecular Diagnostics Cancer Market Share by Region (2016-2027)
    Figure 43. China Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Japan Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. South Korea Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Southeast Asia Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. India Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Australia Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Molecular Diagnostics Cancer Market Share by Type (2016-2027)
    Figure 51. Latin America Molecular Diagnostics Cancer Market Share by Application (2016-2027)
    Figure 52. Latin America Molecular Diagnostics Cancer Market Share by Country (2016-2027)
    Figure 53. Mexico Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Brazil Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Molecular Diagnostics Cancer Market Share by Type (2016-2027)
    Figure 57. Middle East & Africa Molecular Diagnostics Cancer Market Share by Application (2016-2027)
    Figure 58. Middle East & Africa Molecular Diagnostics Cancer Market Share by Country (2016-2027)
    Figure 59. Turkey Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Saudi Arabia Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. UAE Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. Roche Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 63. Danaher Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 64. Siemens Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 65. Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 66. ICON Plc Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 67. AstraZeneca Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 68. MDxHealth Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 69. Invitae Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 70. PlexBio Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 71. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 72. Guardant Health Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 73. Biocartis Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 74. Bio-Techne Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 75. Merck Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 76. Foundation Medicine Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 77. 10X Genomics Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 78. Biodesix Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 79. CytoTrack Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 80. GenomOncology Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 81. Luminex Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Danaher
Siemens
Abbott Laboratories
ICON Plc
AstraZeneca
MDxHealth
Invitae
PlexBio
Thermo Fisher Scientific
Guardant Health
Biocartis
Bio-Techne
Merck
Foundation Medicine
10X Genomics
Biodesix
CytoTrack
GenomOncology
Luminex
Frequently Asked Questions
Molecular Diagnostics Cancer report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Molecular Diagnostics Cancer report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Molecular Diagnostics Cancer report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Healthcare Tourism

Healthcare tourism mainly includes convalescent tourism, leisure vacation tourism, hot spring tou ... Read More